Table 2.
Variable | Total | Death | Other unfavourable | |||||
N | N | OR (95% CI) | p | N | OR (95% CI) | p | ||
Sex | female | 243 | 35 | 1 | 30 | 1 | ||
male | 386 | 73 | 1.41 (0.90–2.204) | 0.15 | 50 | 1.13 (0.69–1.84) | 0.71 | |
Age group | 0 – 44 | 118 | 6 | 1 | 20 | 1 | ||
45 – 64 | 172 | 18 | 2.12 (0.81–5.56) | 0.12 | 24 | 0.85 (0.44–1.63) | 0.62 | |
65 - | 339 | 84 | 5.89 (2.48–13.94) | <0.001 | 36 | 0.75 (0.42–1.38) | 0.36 | |
TB history | no | 570 | 101 | 1 | 76 | 1 | ||
yes | 59 | 7 | 0.57 (0.25–1.29) | 0.21 | 4 | 0.43 (0.15–1.23) | 0.15 | |
Social risk factor1 | no | 330 | 76 | 1 | 33 | 1 | ||
yes | 295 | 32 | 0.43 (0.27–0.68) | <0.001 | 46 | 1.42 (0.87–2.30) | 0.18 | |
Birthplace or nationality | Finland | 603 | 107 | 1 | 72 | 1 | ||
abroad | 26 | 1 | 0.23 (0.031–1.77) | 0.22 | 8 | 2.77 (1.15–6.66) | 0.040 | |
Immunosuppression | no | 548 | 78 | 1 | 76 | 1 | ||
yes | 81 | 30 | 3.22 (1.92–5.42) | <0.001 | 4 | 0.44 (0.15–11.3) | 0.15 | |
Malignancy2 | no | 613 | 102 | 1 | 77 | 1 | ||
yes | 15 | 6 | 4.26 (1.35–13.46) | 0.017 | 3 | 2.82 (0.69–11.5) | 0.15 | |
Diabetes | no | 537 | 86 | 1 | 73 | 1 | ||
yes | 92 | 22 | 1.54 (0.86–2.63) | 0.14 | 7 | 0.58 (0.25–1.31) | 0.21 |
1Information missing for four cases
2Information missing for one case
Significant p-values are darkened.